Iowa Ties Rebound to Biotech Express

AMES, IOWA—The idea that biotechnology can help pull Iowa out of its worst economic crisis in 50 years has won converts in state government and stimulated the interest of companies worldwide. But the millions of dollars flowing into Iowa universities have not altered the view of scientists here that basic research cannot produce a short-term economic bonanza. Throughout the country, states are scrambling to amass expertise in biotechnology and related fields. An array of centers of exce

Written byLorraine Wechsler
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

AMES, IOWA—The idea that biotechnology can help pull Iowa out of its worst economic crisis in 50 years has won converts in state government and stimulated the interest of companies worldwide. But the millions of dollars flowing into Iowa universities have not altered the view of scientists here that basic research cannot produce a short-term economic bonanza.

Throughout the country, states are scrambling to amass expertise in biotechnology and related fields. An array of centers of excellence, industrial-university consortia, and regional alliances are springing up in the hope of grabbing part of the huge economic payoff that goes with becoming the biological Silicon Valley.

Two years ago Iowa launched a marketing campaign to promote its agricultural research facilities and biotechnology industries. Last year the state legislature allocated $50 million of scarce state funds to Iowa State University to bring it up to speed in molecular biology after scientists and seed, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies